AFFYMAX INC

Delisted

CIK 1158223fmd_1QH68HJYRKH9FJC3ZA14ZWJD02Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2014, 18 periods

Income Statement · Annual · Millions · USD
Line item	FY2009	FY2010	FY2011	FY2012	FY2013
Total revenues	115	113	48	94	1
Research and development	157	94	76	52	12
Selling, general and administrative	37	33	33	90	28
Total operating expenses	194	127	109	186	16
Operating income	(79)	(14)	(61)	(92)	(15)
Interest expense	0	0	0	1	2
Interest and investment income	1	0	0	0	0
Other non-operating income (expense)	0	0	0	(0)	0
Income before taxes	(78)	(14)	(61)	(93)	(17)
Income tax expense	(1)	0	0	(0)	(2)
Net income from continuing operations	(77)	(14)	(61)	(93)	(14)
Net income to common shareholders	(77)	(14)	(61)	(93)	(14)